Hexa Reports : Genomics in Cancer Care Industry 2016

Hexa Reports

Market Research Reports and Insightful Company Profiles

Genomics In Cancer Care Industry Share and Size,

Market Analysis, Trends and Growth, End-use And

Segment Forecasts To 2022

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a

new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of

next generation sequencing for the diagnosis & treatment is expected to fuel the market with future

growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and

accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to

identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors

such as cost reduction in genome sequencing, growing healthcare expenditure levels and

development of effective diagnostics & therapeutic procedures for cancer are responsible for the

potential growth of genomics in cancer care.

Browse Detail Report With TOC @ http://www.hexareports.com/report/genomics-in-cancer-caremarket/details

Further key findings from the study suggest:

Instrument segment dominated the overall market in terms of revenue share as of 2014 and

accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are

most widely used product segment in genome testing as they are indispensible component and

frequently required to perform the test.

Demand for services such as next generation sequencing, PCR and other such as cancer risk

management & genetic testing are expected to grow over the forecast period due to increasing

outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing

awareness pertaining to associated benefits with the use of these technologies are high impact

rendering drivers for this segment.

Hexa Reports

Market Research...